Critical

Anaphylaxis in the patient on beta-blockers — glucagon rescue

Adrenaline-resistant anaphylaxis in beta-blocked patients · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Beta-blockade blunts the response to adrenaline and can produce unopposed alpha effects, causing adrenaline-resistant hypotension and bronchospasm in anaphylaxis. Glucagon bypasses the beta-receptor to raise cyclic AMP, restoring inotropy and bronchodilation.

Figures & algorithms

Recognition & management
Recognition & management

Red flags

  • Persistent hypotension despite two IM adrenaline doses
  • Bradycardia unresponsive to atropine
  • Vomiting with reduced consciousness (aspiration risk)
  • Stridor or progressive airway oedema
  • Rising lactate indicating sustained hypoperfusion

Assessment

Differential diagnosis

  • Simple under-treated anaphylaxis
  • Primary cardiogenic shock (bradycardia from beta-blocker overdose)
  • ACE-inhibitor-mediated (bradykinin) angioedema
  • Septic or hypovolaemic shock
  • Vasovagal reaction

Investigations

  • Continuous ECG and blood pressure monitoring
  • Serial mast cell tryptase (resuscitation, 1-2 h, baseline)
  • Blood gas with lactate and glucose
  • 12-lead ECG (bradycardia, blocks, ischaemia)
  • Medication reconciliation confirming beta-blocker use and dose

Management

  • Give IM adrenaline 500 mcg and high-flow oxygen; repeat adrenaline at 5 min
  • Lay flat, raise legs, give rapid crystalloid bolus 500-1000 mL
  • If poor response after two IM doses, give IV glucagon bolus and prepare an infusion
  • Place a nasogastric tube / antiemetic cover as glucagon commonly causes vomiting — protect the airway
  • Escalate to IV adrenaline infusion alongside glucagon if still refractory
  • Add atropine for symptomatic bradycardia and consider additional vasopressor
  • Treat bronchospasm with nebulised salbutamol and ipratropium
  • Involve critical care early; monitor glucose (glucagon causes hyperglycaemia then rebound)

Drugs & doses

Adrenaline IM — 500 mcg (0.5 mL 1:1000), repeat every 5 min
Glucagon — 1-2 mg IV bolus, repeat after 5 min if needed, then infusion 5-15 mcg/min titrated
Atropine — 500 mcg IV, repeat to maximum 3 mg for bradycardia
Adrenaline IV infusion — 1 mg in 100 mL 0.9% saline (10 mcg/mL), titrated under critical care
Salbutamol — 5 mg nebulised, repeated for bronchospasm
Ondansetron — 4 mg IV to counter glucagon-induced vomiting

Disposition

Admit to HDU/ICU for monitored observation of at least 6-12 h, with cardiology/allergy review and medication optimisation before discharge.

Complications & pitfalls

  • Aspiration from glucagon-induced vomiting
  • Refractory shock and cardiac arrest
  • Hyperglycaemia followed by rebound hypoglycaemia
  • Hypokalaemia from combined catecholamine and glucagon therapy
  • Biphasic reaction

Exam pearls

  • Suspect beta-blockade in any adrenaline-resistant anaphylaxis — check the drug chart immediately
  • Glucagon is the key adjunct; have an airway plan because vomiting is near-universal
  • ACE-inhibitor co-prescription further worsens bradykinin-mediated angioedema and response
  • Document the implicated allergen and advise against non-selective beta-blockers at follow-up

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.